1. Roudbary M, Kumar S, Kumar A, Cernáková L, Nikoomanesh F, Rodrigues CF. Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients. J. Fungi. 2021; 7(9): 720.DOI: 10.3390/jof7090720 [
DOI:10.3390/jof7090720] [
PMID] [
]
2. Kadkhodaei M, Sharif MR, Saba MA, Mousavi GA. Assessing the nosocomial infections'rate and the antibiotic resistance pattern among the patient hospitalized in Beheshti Hospital during 2013. Int Arch Health Sci. 2018; 5(1): 11-5. DOI: 10.4103/iahs.iahs_39_17 [
DOI:10.4103/iahs.iahs_39_17]
3. Ebrahimzadeh A, Allahyari E, Nikoomanesh F, Zare_Bidaki M. A Comparative Analysis of Nosocomial Infections between Internal and Surgical Intensive Care Units of a University Hospital in Birjand, Iran from 2015 to 2016: A Retrospective Study. J Bas Res Med Sci. 2021; 8(4):32-41 DOI: 10.21203/rs.3.rs-42477/v1 [
DOI:10.21203/rs.3.rs-42477/v1]
4. Erboga M, Kanter M, Aktas C, Sener U, Erboga ZF, Donmez YB, et al. Thymoquinone ameliorates cadmium-induced nephrotoxicity, apoptosis, and oxidative stress in rats is based on its anti- apoptotic and anti-oxidant properties. Biol Trace Elem Res. 2016; 170(1): 165-72. DOI: 10.1007/s12011-015-0453-x [
DOI:10.1007/s12011-015-0453-x] [
PMID]
5. Nouri N, Mohammadi SR, Beardsley J, Aslani P, Ghaffarifar F, Roudbary M, et al. Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units-An In Vitro Study. Metabolites. 2023; 13(4): 580. DOI: 10.3390/metabo13040580 [
DOI:10.3390/metabo13040580] [
PMID] [
]
6. Khan MA, Aldebasi YH, Alsuhaibani SA, AlSahli MA, Alzohairy MA, Khan A, et al. Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. PLoS One. 2018; 13(12): e0208951. DOI: 10.1371/journal.pone.0208951 [
DOI:10.1371/journal.pone.0208951] [
PMID] [
]
7. Ksiezopolska E, Gabaldón T. Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes. 2018; 9(9): 461. DOI: 10.3390/genes9090461 [
DOI:10.3390/genes9090461] [
PMID] [
]
8. dos Santos ER, Dal Forno CF, Hernandez MG, et al Suscetibilidade de Candida spp. isoladas de hemocultivos, Avaliadas pelos breakpoints dos documentos M27-A3 e M27-S4 do CLSI. Rev Inst Med Trop Sao Paulo. 2014; 56(6): 477-82. DOI: 10.1590/S0036-46652014000600004 [
DOI:10.1590/S0036-46652014000600004] [
PMID] [
]
9. Zarimeidani R, Roudbar mohammadi S, Roudbary M, Nikoomanesh F, Aslani P, Yaalimadad S. In-Vitro Antifungal Activity of Nano Encapsulated Caprylic Acid and EFG1 Gene Expression Profile in Candida albicans. Infect epidemiol microbiol. 2021; 7(3): 229-36. DOI: 10.52547/iem.7.3.229 [
DOI:10.52547/iem.7.3.4]
10. Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022; 20(9): 557-71 DOI: 10.1038/s41579-022-00720-1 [
DOI:10.1038/s41579-022-00720-1] [
PMID] [
]
11. Beardsley J, Halliday CL, Chen SC, Sorrell TC. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Future Microbiol. 2018; 13(10): 1175-91. DOI: 10.2217/fmb-2018-0059 [
DOI:10.2217/fmb-2018-0059] [
PMID] [
]
12. Rahsepar S, Delavari H, Roudbari M, Mohammad Hassan Z. Design and Synthesis of Novel Thymoquinone-Zein Nanoparticles; Evaluation of the Inhibitory Effect on Candida albicans and Biofilm Formation in Vitro. Infect. epidemiol. microbiol. 2022; 8(2): 169-76. DOI: 10.52547/iem.8.2.169 [
DOI:10.52547/iem.8.2.169]
13. Almshawit H, Macreadie I. Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. Microbiol Res. 2017; 195: 81-8. DOI: 10.1016/j.micres.2016.11.008 [
DOI:10.1016/j.micres.2016.11.008] [
PMID]
14. Kaypetch R, Rudrakanjana P, Churnjitapirom P, Tua-Ngam P, Tonput P, Tantivitayakul P. Geraniol and thymoquinone inhibit Candida spp. biofilm formation on acrylic denture resin without affecting surface roughness or color. J Oral Sci. 2022; 64(2): 161-6. DOI: 10.2334/josnusd.21-0435 [
DOI:10.2334/josnusd.21-0435] [
PMID]
15. Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: experience in a tertiary care center. Clinical infectious diseases. 2005; 41(7): 975-81. DOI: 10.1086/432939 [
DOI:10.1086/432939] [
PMID]